MASTOCYTOSIS, SYSTEMIC

Clinical trials for MASTOCYTOSIS, SYSTEMIC explained in plain language.

Never miss a new study

Get alerted when new MASTOCYTOSIS, SYSTEMIC trials appear

Sign up with your email to follow new studies for MASTOCYTOSIS, SYSTEMIC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 1

Extended safety tracking for mast cell disorder drug

Disease control Recruiting now

This study continues monitoring the safety of avapritinib for people with systemic mastocytosis who previously participated in related trials and are still benefiting from the medication. It tracks side effects and safety issues over a longer period. The goal is to better underst…

Matched conditions: MASTOCYTOSIS, SYSTEMIC

Phase: PHASE4 • Sponsor: Blueprint Medicines Corporation • Aim: Disease control

Last updated Apr 01, 2026 14:42 UTC

MASTOCYTOSIS, SYSTEMIC

Get alerted when new MASTOCYTOSIS, SYSTEMIC trials appear

Extended safety tracking for mast cell disorder drug